This interdisciplinary platform development partnership is led by Roswell Park Cancer Institute, with the collaboration of the Institute for Lasers, Photonics and Biophotonics at the University of Buffalo, and the Department of Chemistry at the University of Michigan. The overall goal is to develop targeted nanoparticle (NP) platforms utilizing photodynamic therapy (PDT) and multiple imaging modalities in vivo imaging and multifunctional therapeutics. We envision development, characterization and preclinical validation of multifunctional NP platforms that deliver tumor-avid, therapeutic photosensitizers (PS) that only are active (and toxic) when illuminated by light. The NP also carries a payload of one or more imaging agents, enabling both multimodal diagnosis and image-guided therapy. Selective NP delivery comes from the tumor avidity of the PS and/or from NP surface ligands that recognize targeted cells. Additional therapeutic selectivity is due to local activation of the PS by light. We hypothesize that biocompatible organically modified silicate sol (Ormosil) and polyacrylamide NP will be effective multi-functional nanovectors for tumor therapy and imaging (optical, PET, MR).
Our aims are: 1. To prepare multifunctional Ormosil and polymeric nanovectors capable of both tumor therapy and imaging, which contain tumor-avid PS with or without additional targeting moieties, as well as optical, PET, and/or MRI imaging agents. 2. To characterize the different nanovectors in solution and in vitro and iteratively utilize the data within Aim 1 to select and optimize formulations. 3. To examine selected nanovectors in animal tumor systems and iteratively apply the information to Aims 1 and 2 to further refine the platform development. Allan R. Oseroff, MD, PhD, the PI, will provide overall direction and coordination and will be responsible for the cellular and animal model evaluations. Ravi Pandey, PhD (RPCI), will prepare the photosensitizers and the imaging payloads. Paras Prasad, PhD (UB), will lead development and photophysical characterization of the Ormosil platform. Raoul Kopelman, PhD (UM), will lead development and photophysical characterization the polyacrylamide platform.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRRB-C (O1))
Program Officer
Hull, Lynn C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Chen, Guanying; Roy, Indrajit; Yang, Chunhui et al. (2016) Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy. Chem Rev 116:2826-85
Jenkins, Samir V; Srivatsan, Avinash; Reynolds, Kimberly Y et al. (2016) Understanding the interactions between porphyrin-containing photosensitizers and polymer-coated nanoparticles in model biological environments. J Colloid Interface Sci 461:225-231
Damasco, Jossana A; Chen, Guanying; Shao, Wei et al. (2014) Size-tunable and monodisperse Tm³?/Gd³?-doped hexagonal NaYbF? nanoparticles with engineered efficient near infrared-to-near infrared upconversion for in vivo imaging. ACS Appl Mater Interfaces 6:13884-93
Liu, Sha; Chen, Guanying; Ohulchanskyy, Tymish Y et al. (2013) Facile synthesis and potential bioimaging applications of hybrid upconverting and plasmonic NaGdF4: Yb3+, Er3+/silica/gold nanoparticles. Theranostics 3:275-81
Chen, Guanying; Shen, Jie; Ohulchanskyy, Tymish Y et al. (2012) (?-NaYbF4:Tm(3+))/CaF2 core/shell nanoparticles with efficient near-infrared to near-infrared upconversion for high-contrast deep tissue bioimaging. ACS Nano 6:8280-7
Chen, Guanying; Ohulchanskyy, Tymish Y; Liu, Sha et al. (2012) Core/shell NaGdF4:Nd(3+)/NaGdF4 nanocrystals with efficient near-infrared to near-infrared downconversion photoluminescence for bioimaging applications. ACS Nano 6:2969-77
Gupta, Anurag; Wang, Shouyan; Pera, Paula et al. (2012) Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles. Nanomedicine 8:941-50
Wang, Shouyan; Fan, Wenzhe; Kim, Gwangseong et al. (2011) Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy. Lasers Surg Med 43:686-95
Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny et al. (2011) The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 40:340-62
Ding, Hong; Yong, Ken-Tye; Roy, Indrajit et al. (2011) Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers. Nanotechnology 22:165101

Showing the most recent 10 out of 22 publications